Ronancastled
Well-Known Member
- Messages
- 1,234
- Type of diabetes
- Type 2
- Treatment type
- Diet only
The headline yu remember I think was 46% on 15% loss from the original study.It was just kess than half were classed as Responders. I think DIRECT (whch became a two pass solution) did raise this by a small amount but it was still around 50%. It was certainly clarioned that the weight loss had to be around 15%https://www.diabetes.org.uk/about_u...ssion-least-five-years-reveal-latest-findings
https://twitter.com/x/status/1648574761973293056
This hit the news channels yesterday, only picking up on it now.
Not as inspiring as I might have hoped.
View attachment 60476
Think I remember the initial headline data spoke about 76% achieving remission with 15kg weight loss.
Obviously those large weight loss amounts have tapered over time, would like to see a more detailed analysis of those 11 remaining successful candidates .
Weight loss may be the key for obese T2s but maintaining seems a greater struggle.
Don't forget either that the ND diet based on shakes is also LC but not HF. It was designed to run so that the majority just avoided going into ketosis.I strongly suspect that Dr Unwin's patients on Low Carb have a better remission rate after 5yrs.
So it works for 23% of the original study who originally had to lose 15% of body mass, and now seem to maintian at 8.9 kg less. Not clear if that is additional loss on the 15% or is actual loss from the starting value ( it is identified as a 5 year average loss).
It does look like taking the ND original startpoint the interevention had a 5 year success rate of 11 out of 149 i.e. 7% in remisssion due to the diet. Looking less impressive every time they trumpet success. I suggest the Unwin trials may very well be more rewarding.View attachment 60479
So there was 68 people out of 149 who maintained remission at 1 year.
View attachment 60478
So that 68 decayed to 48 at Year 2 & further to only 11 at Year 5.
View attachment 60480
So there is the real headline figure.
The real takeaway here is the difficulty in maintaining the weight loss.
Perhaps this strengthens Taylor's hypothesis
Also worth noting that those original 149 were specially chosen too, <6 years T2 duration, BMI > 27, no insulin users.It does look like taking the ND original startpoint the interevention had a 5 year success rate of 11 out of 149 i.e. 7% in remisssion due to the diet. Looking less impressive every time they trumpet success.
That is why until 2009 the NICE Guidelines always started their T2D roadmap for treatment with Step 1 = weight loss and lifestyle changes, before prescribing medication. Now NG 28 starts with immediate Metformin and additional SGLT2 if you have kidney problems. I note that in USA the SGLT2 is contraindicated if eGFR< 45 but in UK its free sweeties for everybody and beggar the consequences.Also worth noting that those original 149 were specially chosen too, <6 years T2 duration, BMI > 27, no insulin users.
Funnily enough that 7% success rate isn't far off the 5% observed by all T2s in the 2019 Scottish study.
https://pubmed.ncbi.nlm.nih.gov/34727107/
Only positive takeaway for Taylor is that the weight loss hypothesis appears to be confirmed
In that case I must be in remission from T1, if it doesn't matter if you're on medication!The Taylor definition of remission is HbA1c below 48. and that is with or without meds.
The original definition did not mention medication because the trial itself stopped all diabetic medications. I believe it now defines it as <48 and not using any T2D medication. Insulin users were excluded from the studies.In that case I must be in remission from T1, if it doesn't matter if you're on medication!
Aw, too bad.The original definition did not mention medication because the trial itself stopped all diabetic medications. I believe it now defines it as <48 and not using any T2D medication. Insulin users were excluded from the studies.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?